CoChat

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature

Open access
Hesse, Morten · 2009 · BMC Psychiatry

Abstract

BACKGROUND: There is an increasing consensus in favour of integrated treatment of substance use disorders and co-morbid conditions, such as depression or anxiety. However, up till now no systematic reviews have been published. METHODS: Based on a systematic search of MedLine and PsychInfo, 9 trials of integrated treatment for depression or anxiety plus substance use disorder were identified. Where possible, meta-analyses were carried out, using random effects models. RESULTS: Meta-analyses were carried out for integrated treatment for depression and substance use disorders on a number of outcomes. No meta-analysis could be carried out for integrated treatment for anxiety and substance use disorders, due to multivariate reporting of outcomes in original articles. Integrated treatment for depression and substance abuse produced significant effects on percent days abstinent at follow-up. Differences in retention and symptoms were non-significant, but favoured the experimental condition. For studies of integrated treatment for co-morbid anxiety disorders and substance use disorders, no meta-analysis could be carried out. Several studies of integrated treatment for anxiety and substance use disorders reported that patients assigned to substance use treatment only fared better. CONCLUSION: Psychotherapeutic treatment for co-morbid depression and substance use disorders is a promising approach, but is not sufficiently empirically supported at this point. Psychotherapeutic treatment for co-morbid anxiety and substance use disorders is not empirically supported. There is a need for more trials to replicate the findings from studies of integrated treatment for depression and substance use disorders, and for the development of new treatment options for co-morbid anxiety and substance use disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-244x-9-6

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Hamilton Rating Scale for Depression outcomes. Notes: SD: Standard deviation. Z is the Zeta statistic for significance of pooled effect size. I2 is the degree of heterogeneity of the effect size. CI: Confidence interval.
Figure 1 Hamilton Rating Scale for Depression outcomes. Notes: SD: Standard deviation. Z is the Zeta statistic for significance of pooled effect size. I2 is the degree of heterogeneity of the effect size. CI: Confidence interval.CC BY · PubMed Central
Figure 2 Self-reported depressive symptoms outcome (SCL-90 or BDI). Notes: SD: Standard deviation. Z is the Zeta statistic for significance of pooled effect size. I2 is the degree of heterogeneity of the effect size. CI: Confidence interval.
Figure 2 Self-reported depressive symptoms outcome (SCL-90 or BDI). Notes: SD: Standard deviation. Z is the Zeta statistic for significance of pooled effect size. I2 is the degree of heterogeneity of the effect size. CI: Confidence interval.CC BY · PubMed Central
Figure 3 Percent days abstinent outcomes. Notes: SD: Standard deviation. Z is the Zeta statistic for significance of pooled effect size. I2 is the degree of heterogeneity of the effect size. CI: Confidence interval.
Figure 3 Percent days abstinent outcomes. Notes: SD: Standard deviation. Z is the Zeta statistic for significance of pooled effect size. I2 is the degree of heterogeneity of the effect size. CI: Confidence interval.CC BY · PubMed Central
Figure 4 Drop-out from treatment outcomes. Notes: SD: Standard deviation. Z is the Zeta statistic for significance of pooled effect size. I2 is the degree of heterogeneity of the effect size. CI: Confidence interval.
Figure 4 Drop-out from treatment outcomes. Notes: SD: Standard deviation. Z is the Zeta statistic for significance of pooled effect size. I2 is the degree of heterogeneity of the effect size. CI: Confidence interval.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 130

Metadata

Authors
Hesse, M.
Affiliations
Aarhus University (DK)
Corresponding author
Hesse, Morten
Venue
BMC Psychiatry
Published
2009-02-20
Volume
9
Issue
1
Pages
6-6
ISSN
1471-244X (ISSN-L)
OpenAlex
W2013084379
Cited by
130
References
22
Citations by year
2026: 2 · 2025: 5 · 2024: 10 · 2023: 3 · 2022: 7 · 2021: 5 · 2020: 9 · 2019: 7 · 2018: 9 · 2017: 7 · 2016: 7 · 2015: 9 · 2014: 12 · 2013: 8 · 2012: 9
FWCI
1.13
Type
journal article
Language
en
Open access
Locations
  • BMC Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
integrated treatment, substance use disorders, depression, anxiety disorders, comorbidities, psychotherapy, treatment retention, abstinence, treatment outcomes
MeSH terms
Anxiety, Depression, Humans, Psychiatric Status Rating Scales, Psychotherapy, Randomized Controlled Trials as Topic, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. https://app.cochat.ai/papers/10.1186/1471-244x-9-6
The paper
Hesse, M. (2009). Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry. https://doi.org/10.1186/1471-244x-9-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.